SPAC scrapped, Baring puts CitiusTech on the block for $2.2 bln

By Sumit Blogs -

Less than a year after calling off plans for a SPAC listing in the US, Baring Private Equity Asia (BPEA) is all set to sell its controlling stake in healthcare analytics firm CitiusTech.

BPEA is engaged in talks with a clutch of global buyout funds including Blackstone, TPG and KKR to sell CitiusTech in a deal valuing the firm at around $2-2.2 billion (Rs.15,000 cr), said multiple people aware of the development.

JPMorgan is understood to be running a formal process to find a buyer.

In 2019, Baring PE Asia outbid top funds Blackstone, KKR, CVC Capital and Bain Capital to acquire CitiusTech for $1 billion (Rs7,500 cr) and a successful deal will help it more than double the money in less than three years.

KKR, Blackstone spokespersons declined to comment. Mails sent to BPEA, TPG remained unanswered.


CitiusTech, founded by IIT-Bombay graduates Koita and Jagdish Moorjani in 2005, provides healthcare technology services and solutions. Koita was the founder and CEO of Transworks BPO, which was sold to the Aditya Birla Birla Group in 2003. He set up Citius-Tech in 2005 with fellow IIT batchmate Moorjani.

The private equity firm had acquired about 80% of CitiusTech, from existing investors including General Atlantic. CitiusTech had raised $111 million in 2014 from General Atlantic by selling about 32% stake. BPEA acquired the remaining stake from the founders. Founders and employees still own 20% stake.

CitiusTech provides healthcare technology services, solutions and platforms to more than 130 organizations across the payer, provider, medical technology and life sciences markets. With more than 5,000 technology professionals worldwide, CitiusTech focuses on healthcare interoperability & data management, connected health, virtual care coordination & delivery, personalized medicine and population health management.

Its clients include US-based Geisinger Health, DaVita and Centra Health.

In October, CitiusTech had hired Bhaskar Sambasivan as its chief executive officer, replacing co-founder Rizwan Koita. Last year, CitiusTech had acquired SDLC Partners, a payer-focused technology solutions company, in Pittsburgh.

Healthcare technology deals were on the high in 2021 thanks to an increased focus on IT and enabled services amid the pandemic. Last year, Baring Asia acquired a controlling stake in the healthcare BPO unit of Hinduja Global Solutions for around $1 billion. Carlyle Group acquired Hexaware from Baring while Blackstone consolidated its position with a $2.8-billion Mphasis bet.

PE deal activity surged to an all-time high in 2021, with technology dominating the deal activity, attracting investments to the tune of $40 billion, PwC said in a note in February. Meanwhile, more than 10 technology-driven startups raised in excess of $7.36 billion in 2021 from the public markets through their IPOs, setting the base for Indian unicorns to tap capital markets.

Credits – Source – https://ift.tt/0hQV5qw

The post SPAC scrapped, Baring puts CitiusTech on the block for $2.2 bln appeared first on Stay in Gurgaon.

Comments

Post a Comment

Popular posts from this blog

Flat sale of flu drugs hints at no unusual rise in infections

By Sumit Blogs -
Image
By Economic Times – Flat sale of flu drugs hints at no unusual rise in infections Industry executives and chemists said the April sales data showed a month-on-month decline of 30-40%. But even though the lockdown is seen to be impacting sales of most drugs, the pattern for medicines for infections and flus is no different.Last Updated: Apr 30, 2020, 11.23 AM ISTAgenciesExperts said the decline in sales was primarily because of the lockdown and other restrictions which forced people to stay indoors. (This story originally appeared in on Apr 30, 2020)NEW DELHI: Sales of anti-infectives (antibiotics and antivirals), respiratory drugs, painkillers and analgesics — some key medicines used for influenza-like illnesses — have remained mostly unchanged in last three months (January to March), partly explained by the lockdown but also indicating no unusual rise in flu-type infections that might point to a wider and undetected spread of Covid-19. Sales of most medicines, including this set of
Read more

10YearsForSimha: Reasons behind film’s success

By Sumit Blogs -
Image
By Times of India – 10YearsForSimha: Reasons behind film’s success TIMESOFINDIA.COM | Last updated on – Apr 30, 2020, 06:00 ISTclose01/6Take a look at the reasons behind the film’s successDirected by Boyapati Srinu, the 2010 film Simha was a game-changer among Tollywood films that was lauded, not only for Nandamuri Balakrishna’s intense performance in the dual role but also the gripping narration of the filmmaker. Balayya and Nayanthara were seen on the big screen for the first time ever in the film. The action drama made a special place in the hearts of the audience because of its simple storytelling, superhit songs and unbeatable chemistry between the lead pair. The movie has completed a decade, but the essence is as fresh as it was back then. As the film clocks 10 years of its release, find out the reasons behind the massive success of the Balakrishna starrer.readmore02/6​Boyapati Srinu’s gripping narrationBefore Simha, Boyapati Srinu had delivered Bhadra (2005) and Tulasi (2007),
Read more

Hrithik-Saif’s Vikram Vedha hits a roadblock

By Sumit Blogs -
Image
The stage was about to be set for Hrithik Roshan and Saif Ali Khan’s ‘Vikram Vedha’ in Mumbai’s Film City. The material had reached. The artisans had been hired. But the lights have now been dimmed. Madhavan and Vijay Sethupathi’s hit movie Vikram Vedha’s Hindi remake will not go on floors by mid-July as per the original plan. The new delta virus of COVID has sent shudders down many spines and many films which were being laid out on an expansive scale have been either held back or shifted their shoots abroad. The first schedule of this Hrithik-Saif movie will now be shot abroad. A source says, “The Mumbai schedule will be done but later.” Adds the source, “It’s a call that was taken yesterday. It wasn’t an easy call to take, no doubt, but the fact that it’s going to be a costly set made the makers take the safer route rather than be sorry later.” When contacted, General Secretary of FWICE (Federation of Western India Cine Employees), Ashok Dubey, confirmed that the makers of ‘V
Read more